Mestinon (Pyridostigmine) for Myasthenia Gravis

Overview
- Drug Class: Cholinesterase inhibitors.
- Mechanism: Works by breaking down acetylcholine to improve communication between nerves and muscles, reducing muscle weakness.
- Forms Available: Tablet, syrup, and time-release formula (Mestinon Timespan).
- Dosage: read more

Mestinon (Pyridostigmine) for Myasthenia Gravis

Overview:
- Drug Class: Cholinesterase inhibitors.
- Mechanism: Works by breaking down acetylcholine to improve communication between nerves and muscles, reducing muscle weakness.
- Forms Available: Tablet, syrup, and time-release formula (Mestinon Timespan).
- Dosage: Typically taken once or twice daily as recommended by a doctor based on symptoms.

Common Side Effects:
- Stomach pain
- Nausea
- Vomiting
- Diarrhea
- Muscle cramps
- Sweating
- Increased salivation
- Rash
- Blurry vision
- Coughing

Serious Side Effects:
- Loss of movement or extremely weak muscles
- Shallow breathing
- Slurred speech
- Trouble with vision
- Allergic reactions

Additional Information:
- FDA Approval: Mestinon is approved by the U.S. Food and Drug Administration (FDA) to treat myasthenia gravis.
- Patient Experience: 416 people have indicated they have taken Mestinon.

For more detailed information, you can visit the [Mestinon page on MGteam](https://www.MGteam.com/treatments/mestinon).

 This AI-generated response comes from MGteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Mestinon (Pyridostigmine) for Myasthenia Gravis | MGteam

9 Treatment Options for Myasthenia Gravis: Medication, Surgery, and More | MGteam